Dutch researchers randomized 120 patients with acute gouty arthritis and no contraindications to NSAIDs to receive either oral prednisolone (35 mg daily) or naproxen (500 mg twice daily ...
Antibe Therapeutics has announced that it has received approval from Health Canada to initiate a Phase 2, double-blind, gastrointestinal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback